New hope for Kids' diarrhea: drug plus fluids tested
NCT ID NCT07285785
First seen Jan 10, 2026 · Last updated Jun 19, 2026 · Updated 18 times
Summary
This study tests how the drug rifaximin (Xifaxan) works in children aged 6 to 11 with acute diarrhea likely caused by bacteria. Half the children get the drug plus oral rehydration therapy, the other half get rehydration alone. Researchers want to see if adding the drug helps diarrhea resolve faster and is safe for kids.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Direct Helpers
NOT_YET_RECRUITINGHialeah, Florida, 33012, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LinQ Research
RECRUITINGRosharon, Texas, 77583, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oceane7 Medical & Research Center, Inc
RECRUITINGMiami, Florida, 33144, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SouthCoast Research Center
RECRUITINGMiami, Florida, 33136, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tekton Research
RECRUITINGRichmond, Virginia, 23233, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
rifaximin (Xifaxan) 200 mg tablet
What this could lead to
If it works, this could provide a new treatment option for bacterial diarrhea in children, shortening illness and reducing symptoms.
What could go wrong
This is a small Phase 4 study with only 54 children, so results may not apply broadly. Rifaximin may not speed recovery over rehydration alone, and side effects are possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.